Cargando…

Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease

OBJECTIVE: To explore the clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease. METHOD: An analytic approach of the reviewing method was adopted to analyze the clinical data of 80 breast cancer patients who were admitted to our hospital f...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jie, Liu, Yonghong, Jin, Jian, Shi, Qingfeng, Ji, Yanting, Zhang, Bo, Hu, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156457/
https://www.ncbi.nlm.nih.gov/pubmed/37152372
http://dx.doi.org/10.1155/2023/3133554
_version_ 1785036543915720704
author Li, Jie
Liu, Yonghong
Jin, Jian
Shi, Qingfeng
Ji, Yanting
Zhang, Bo
Hu, Pengfei
author_facet Li, Jie
Liu, Yonghong
Jin, Jian
Shi, Qingfeng
Ji, Yanting
Zhang, Bo
Hu, Pengfei
author_sort Li, Jie
collection PubMed
description OBJECTIVE: To explore the clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease. METHOD: An analytic approach of the reviewing method was adopted to analyze the clinical data of 80 breast cancer patients who were admitted to our hospital from January 2020 to January 2022. They were divided into an observation group (breast cancer with thyroid lesions) and a control group (simple breast cancer) according to whether the clinical data were accompanied with thyroid lesions to compare the clinical characteristics, pathological types, staging characteristics, and molecular biological characteristics of the two groups and to research the risk factors of the two groups. RESULT: (1) In the comparison of clinical data, the number of people aged ≥60 in the observation group was higher than that in the control group, and there was significant difference between the groups in the menopausal status data (P < 0.05). There was no statistical difference between the observation group and the control group in the comparison of clinical data of the body mass index, pregnancy frequency, labor frequency, and abortion history (P > 0.05). (2) In the comparison of pathological type and staging data, there was no statistical difference in the comparison of data on the pathological type, histological grade, T staging, N staging, and TNM staging between the observation group and the control group (P > 0.05). (3) In the comparison of data on molecular biology characteristics, there was a statistical difference in the nuclear proliferation antigen data between the observation group and the control group (P < 0.05). There was no statistical difference in the comparison of data on the estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, and molecular typing between the observation group and the control group (P > 0.05). (4) Logistic regression analysis showed that age, menopausal status, and nuclear proliferation antigen index were the high-risk inflammatory factors for combined thyroid lesions (P < 0.05). CONCLUSION: For patients with simple breast cancer, age, menopausal status, and nuclear proliferation antigen index are risk factors for combined thyroid lesions. Therefore, clinical attention should be paid to the above factors in the process of clinical treatment, and early-risk screening should be performed to achieve the purpose of improving the prognosis to the greatest extent.
format Online
Article
Text
id pubmed-10156457
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-101564572023-05-04 Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease Li, Jie Liu, Yonghong Jin, Jian Shi, Qingfeng Ji, Yanting Zhang, Bo Hu, Pengfei Mediators Inflamm Research Article OBJECTIVE: To explore the clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease. METHOD: An analytic approach of the reviewing method was adopted to analyze the clinical data of 80 breast cancer patients who were admitted to our hospital from January 2020 to January 2022. They were divided into an observation group (breast cancer with thyroid lesions) and a control group (simple breast cancer) according to whether the clinical data were accompanied with thyroid lesions to compare the clinical characteristics, pathological types, staging characteristics, and molecular biological characteristics of the two groups and to research the risk factors of the two groups. RESULT: (1) In the comparison of clinical data, the number of people aged ≥60 in the observation group was higher than that in the control group, and there was significant difference between the groups in the menopausal status data (P < 0.05). There was no statistical difference between the observation group and the control group in the comparison of clinical data of the body mass index, pregnancy frequency, labor frequency, and abortion history (P > 0.05). (2) In the comparison of pathological type and staging data, there was no statistical difference in the comparison of data on the pathological type, histological grade, T staging, N staging, and TNM staging between the observation group and the control group (P > 0.05). (3) In the comparison of data on molecular biology characteristics, there was a statistical difference in the nuclear proliferation antigen data between the observation group and the control group (P < 0.05). There was no statistical difference in the comparison of data on the estrogen receptor, progesterone receptor, human epidermal growth factor receptor-2, and molecular typing between the observation group and the control group (P > 0.05). (4) Logistic regression analysis showed that age, menopausal status, and nuclear proliferation antigen index were the high-risk inflammatory factors for combined thyroid lesions (P < 0.05). CONCLUSION: For patients with simple breast cancer, age, menopausal status, and nuclear proliferation antigen index are risk factors for combined thyroid lesions. Therefore, clinical attention should be paid to the above factors in the process of clinical treatment, and early-risk screening should be performed to achieve the purpose of improving the prognosis to the greatest extent. Hindawi 2023-04-26 /pmc/articles/PMC10156457/ /pubmed/37152372 http://dx.doi.org/10.1155/2023/3133554 Text en Copyright © 2023 Jie Li et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Li, Jie
Liu, Yonghong
Jin, Jian
Shi, Qingfeng
Ji, Yanting
Zhang, Bo
Hu, Pengfei
Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title_full Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title_fullStr Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title_full_unstemmed Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title_short Study on Clinicopathological Features and Risk Factors of Patients with Multiple Primary Breast Cancers and Thyroid Disease
title_sort study on clinicopathological features and risk factors of patients with multiple primary breast cancers and thyroid disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156457/
https://www.ncbi.nlm.nih.gov/pubmed/37152372
http://dx.doi.org/10.1155/2023/3133554
work_keys_str_mv AT lijie studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT liuyonghong studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT jinjian studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT shiqingfeng studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT jiyanting studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT zhangbo studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease
AT hupengfei studyonclinicopathologicalfeaturesandriskfactorsofpatientswithmultipleprimarybreastcancersandthyroiddisease